Advertisement
Letter to the editor|Articles in Press

Comment on: The assessment of the long-term prognosis of burning mouth syndrome following treatment necessitates a reappraisal

Published:February 08, 2023DOI:https://doi.org/10.1016/j.ijom.2023.01.011
      Despite the importance of studies evaluating the long-term prognosis of burning mouth syndrome (BMS), there is a paucity of reliable literature available on this subject. We read with interest a recently published article by Kim et al.,
      • Kim M.J.
      • Choi J.H.
      • Kho H.S.
      Long-term prognosis of burning mouth syndrome following treatment.
      titled “Long-term prognosis of burning mouth syndrome following treatment”, which concluded that the long-term prognosis of BMS was good in patients who responded well to treatment, and that xerostomia and taste disturbance were associated with a relapse of oral discomfort in some of the responders. We appreciate the author’s elaborate work on a subject with scarce data in the literature and take this chance to put forth some of our perspectives on the study.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to International Journal of Oral and Maxillofacial Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kim M.J.
        • Choi J.H.
        • Kho H.S.
        Long-term prognosis of burning mouth syndrome following treatment.
        Int J Oral Maxillofac Surg. 2022; 51: 1538-1544
        • Pergolizzi J.V.
        • LeQuang J.A.
        Reappraising the use of benzodiazepines in chronic pain patients.
        Postgrad Med. 2020; 132: 10-12
        • Guina J.
        • Merrill B.
        Benzodiazepines I: upping the care on downers: the evidence of risks, benefits and alternatives.
        J Clin Med. 2018; 717
        • Suga T.
        • Tu T.T.
        • Nagamine T.
        • Toyofuku A.
        Careful use of clonazepam and alpha lipoid acid in burning mouth syndrome treatment.
        Oral Dis. 2022; 28: 846-847
        • Reddy S.
        • Patt R.B.
        The benzodiazepines as adjuvant analgesics.
        J Pain Symptom Manag. 1994; 9: 510-514
        • Watanabe M.
        • Takao C.
        • Liu Z.
        • Nayanar G.
        • Suga T.
        • Hong C.
        • Tu T.T.H.
        • Yoshikawa T.
        • Takenoshita M.
        • Motomura H.
        • Nagamine T.
        • Toyofuku A.
        The effectiveness and adverse events of amitriptyline and aripiprazole in very elderly patients with BMS.
        Front Pain Res. 2022; 3809207